Venus Aesthetic Intelligence

📍 Toronto, Canada🗓 Founded 2009👥 438 employees💰 Last funded Dec 2021
Venus: A Global Leader In The Medical Aesthetics Industry We use cutting-edge technology to develop safe, non-invasive devices that address todays most in-demand aesthetic needs. As a leading medical aesthetic device company, we are currently present in over 60 countries and 29 direct markets with more than 10 million Venus treatments performed worldwide annually. Staying connected to our customers enables us to be focused on their needs and expectations and always provide them with the highest level of care – this is the essence of Aesthetic intelligence. Our latest innovations like Venus Bliss MAX™ the 3-in1-body shaping solution, ARTAS iXi® the A.I. hair restoration robot, NeoGraft®, Venus Legacy,™ Venus Velocity,™ Venus Viva™ MD—are setting higher industry standards and improving the quality of life for hundreds of thousands of patients worldwide. Looking to try a treatment? Find a certified provider near you: ‪http://www.venustreatments.com Are you a physician? Find out more: www.venus.ai
5
Total investors
0
Early stage
2
Mid stage
1
Late stage
2009
Founded
Investor geography2 countries
United States
3
Canada
1
Investor activity2014–2021 · investors recorded per year
20142201712019120211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Venus Aesthetic Intelligence?
Venus Aesthetic Intelligence has 5 investors on record on gritt.io, 2 mid-stage and 1 late-stage investors.
When did Venus Aesthetic Intelligence last raise funding?
The most recent investment in Venus Aesthetic Intelligence recorded on gritt.io was in December 2021.
When was Venus Aesthetic Intelligence founded?
Venus Aesthetic Intelligence was founded in 2009.
What industry is Venus Aesthetic Intelligence in?
Venus Aesthetic Intelligence operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Venus Aesthetic Intelligence based?
Venus Aesthetic Intelligence is headquartered in Toronto, Canada.